Samantha is a registered patent agent with a background in chemistry and significant patenting experience in the pharmaceutical, chemical, and biotech spaces. She focuses her practice on US and international patent prosecution and counseling, managing large-scale patent portfolios, IP due diligence, and patent opinion work. Samantha advises life sciences and chemical companies of all sizes, including clinical-stage biotechnology companies and midsize pharmaceutical businesses.
Prior to joining Mintz, Samantha worked as a patent agent and earlier as a technology specialist at a global law firm. She was also a technical specialist/scientific advisor at an intellectual property law firm.
Samantha has experience with multistep, organometallic, and classical synthesis techniques as well as diverse analytical chemistry approaches including Chiral HPLC, assorted optical analytical techniques, and X-ray crystallography.
She completed her doctoral work in synthetic organic chemistry with a focus on chirality and analytical molecular recognition assays. While earning her PhD, Samantha served as a technical development lead/visiting researcher-scholar for a company developing reagent kits for the high-throughput discovery of asymmetric reactions and as a graduate teaching assistant.
News & Press
Mintz Advises on Benitec Biopharma’s $80 Million Follow-On Offering and Concurrent $20 Million Registered Direct Offering
November 12, 2025
Mintz advised the underwriters in connection with Benitec Biopharma’s follow-on public offering of 5,930,000 shares of common stock at a public offering price of $13.50 per share, and the placement agents in the concurrent registered direct offering of 1,481,481 shares of common stock at an offering price of $13.50 per share. The aggregate gross proceeds to Benitec Biopharma from these offerings were approximately $100 million before deducting underwriting discounts and commissions, placement agent fees, and other offering expenses. In addition, Benitec Biopharma granted the underwriters a 30-day option to purchase up to an additional 889,500 shares of its common stock at the public offering price.
Publications
- Co-author, "Ninhydrin Revisited: Quantitative Chirality Recognition of Amines and Amino Alcohols Based on Nondestructive Dynamic Covalent Chemistry," Journal of Organic Chemistry (September 2020)
- Co-author, "High-throughput Determination of Enantiopurity by Microplate Circular Dichroism," Journal of Organic Chemistry (August 2020)
- Co-author, "Predictive Chirality Sensing via Schiff Base Formation," Organic & Biomolecular Chemistry (July 2019)
- Co-author, "Optical Analysis of Reaction Yield and Enantiomeric Excess: A New Paradigm Ready for Prime Time," Journal of the American Chemical Society (July 2018)
- Co-author, "Biomimetic Chirality Sensing with Pyridoxal-5′-phosphate," Journal of the American Chemical Society (January 2017)
Involvement
- Member, American Chemical Society (2014 – present)
- Member, Chemical Society of Washington (2015 – 2020)
- Assistant Chair, Younger Chemists Committee (2016 – 2018)
- Committee Member, Project SEED (2016 – 2018)
- Youth Outreach Volunteer, Georgetown University Chemistry Department (2016 – 2017)